Making Life Simpler —That’s Our Approach to Innovation

Compare available products

We believe that innovation is the key to simplifying life for people with diabetes

Pod shown without the necessary adhesive.

People with diabetes make an average of 300 decisions each day1 in managing their condition. Our goal is to reduce the burden of diabetes care and simplify the user experience. Our mission is to create insulin delivery that adapts to changing diabetes needs.

Innovation in Every Pod

One small, tubeless and waterproof2 Pod, which is made up of 74 pieces, consistently and accurately delivers insulin for people with diabetes through customizable basal rates and bolus presets.

The Pod holds up to 200 units of rapid-acting U-100 insulin and replaces up to 14 daily injections.3

The Pod includes auto-cannula insertion, that eliminates the necessity of handling the insertion needle, while providing a virtually pain-free path to insulin delivery.

“The Pod is a revolution in insulin therapy. No tubes, less needle sticks, constant insulin delivery for 3 days — no disconnect. All of these factors improve adherence among people with diabetes and, as a result, dramatically improve clinical outcomes and quality of life.

Dr. Michael R. Brennan D.O., M.S., F.A.C.E., F.A.C.P., is an award-winning endocrinology, diabetes and metabolism specialist and founder of the Beaumont Endocrine Center.

Dr. Brennan is a paid consultant of Insulet Corporation, however, the views expressed in this testimony are his own.

Insulet Product Roadmap

We are dedicated to reducing complexity and making diabetes management simpler. Our ongoing commitment to the diabetes community is our continuous innovation, aiming to make products smarter and simpler.

Omnipod® Insulin Management System

Omnipod DASH® Insulin Management System

What’s next?

Get the latest news about Omnipod®

Hear from Industry Experts
and Innovation Leaders

“Our research and development team continues to push the boundaries of what’s possible. Through device miniaturization, therapy automation through artificial intelligence, and integration with consumer technologies, we create simple products that deliver great outcomes and reduce the burden for people with diabetes — and those who care for them.”

—Eric Benjamin SVP, Innovation and Strategy, Insulet Corporation

Awards & Recognition

Our greatest reward is the impact our products have on the people who use them and their caregivers. We’re also pleased that our hard work and advanced approach have been recognized by industry organizations.


  • Top Ten Wearable Medical Device Solution Provider, according to MD Tech Review


  • Top Ten Wearable Medical Device Solution Provider, according to MD Tech Review
  • Omnipod DASH® System named the 2020 Product of the Year in the Health Systems Category by 40,000 U.S. Consumers
1. Harvard T.H. Chan School of Public Health “300 Decisions Every Day: Highlight from The Diabetes Epidemic”
2. The Pod has an IP28 rating for up to 7.6 m (25 feet) for 60 minutes. The PDM is not waterproof.
3. 14 injections/day based on people with T1D on MDI taking ≥ 3 bolus and 1-2 basal injections/day multiplied by 72 hours. Chiang et al. Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association. Diabetes Care. 2014:37:2034-2054.

Regional Disclaimer

Are you a resident of Canada?

Yes No

The content of the webpage that you are about to access is exclusively reserved for residents of Canada.

If you are a resident of Canada, please click 'Yes' to continue. If not, please click 'No' to exit and do not access the webpages. If you selected this country/language in error, you can go back to the previous page and select your country/language.

Thank you.

Please verify that you are a Healthcare Professional.

The content on this section of our website is intended for Canadian Healthcare Professionals only.

If you are not a Canadian Healthcare Professional, you will be redirected to the Omnipod® Homepage.

License number is required.